Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Emerging Artificial Intelligence Technologies for Risk Assessment and Management in Acute Myeloid Leukemia
1
Zitationen
7
Autoren
2025
Jahr
Abstract
AI technologies hold potential to improve AML treatment through enhanced risk stratification, early detection capabilities, and individualized treatment optimization. The transition toward explainable AI models is essential to clinical readiness, with federated learning architectures resolving data scarcity concerns. Seamless integration requires harmonized data standards, robust regulatory frameworks, and equitable access to technology to fully realize the transformative potential of AI in improving outcomes for patients with AML globally.
Ähnliche Arbeiten
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 · 10.090 Zit.
Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell
1997 · 6.906 Zit.
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
2016 · 5.802 Zit.
Proposals for the Classification of the Acute Leukaemias F<scp>rench</scp>‐A<scp>merican</scp>‐B<scp>ritish</scp> (FAB) C<scp>o‐operative</scp> G<scp>roup</scp>
1976 · 5.589 Zit.
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
2013 · 5.093 Zit.